Furthermore, drug sensitivity analysis identified several chemotherapeutic agents that could potentially exhibit enhanced efficacy in gliomas with high CD180 expression, thereby emphasizing promising strategies for chemotherapy. Here, CD180 is linked to central nervous system cancer.